Abstract
Two hundred forty-eight human immunodeficiency virus (HIV)-positive and 496 HIV-negative subjects in Uganda were tested by HerpeSelect herpes simplex virus type 2 enzyme-linked immunosorbent assay (ELISA) and Western blotting to optimize the ELISA for use in this population. A higher index cutoff value was required for optimal sensitivity and specificity, and overall performance of the assay was not affected by HIV status.
Original language | English (US) |
---|---|
Pages (from-to) | 1794-1796 |
Number of pages | 3 |
Journal | Journal of clinical microbiology |
Volume | 42 |
Issue number | 4 |
DOIs | |
State | Published - Apr 2004 |
Externally published | Yes |
ASJC Scopus subject areas
- Microbiology (medical)